Skip to main content

Bruker Will Use HDC's SVM Technology in ClinProTools Product Line

NEW YORK (GenomeWeb News) — Bruker BioSciences today said it has obtained a non-exclusive worldwide license from Health Discovery Corporation to use its Support Vector Machine (SVM) technology in Bruker Daltonics’ ClinProTools clinical proteomics product line.
 
ClinProTools is a bioinformatics product for biomarker panel analysis, biofluid profiling, multivariate data analysis, classical statistics, and sample classification.
 
SVMs are supervised classification algorithms that can analyze high-dimensional mass spectrometric data from a plurality of sample cohorts and “complement” the use of other classification algorithms, such as Bruker’s Supervised Neural Network, its QuickClassifier, modified genetic algorithms, and others,” according to Bruker.
 
The agreement provides for an up-front fee and royalties based on sales. Financial details were not disclosed.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.